These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15321712)

  • 1. Cooperative binding of tetrameric p53 to DNA.
    Weinberg RL; Veprintsev DB; Fersht AR
    J Mol Biol; 2004 Aug; 341(5):1145-59. PubMed ID: 15321712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How p53 binds DNA as a tetramer.
    McLure KG; Lee PW
    EMBO J; 1998 Jun; 17(12):3342-50. PubMed ID: 9628871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative binding of p53 to its promoter and DNA recognition elements.
    Weinberg RL; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2005 May; 348(3):589-96. PubMed ID: 15826656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA bending due to specific p53 and p53 core domain-DNA interactions visualized by electron microscopy.
    Cherny DI; Striker G; Subramaniam V; Jett SD; Palecek E; Jovin TM
    J Mol Biol; 1999 Dec; 294(4):1015-26. PubMed ID: 10588903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
    Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding.
    Rippin TM; Freund SM; Veprintsev DB; Fersht AR
    J Mol Biol; 2002 May; 319(2):351-8. PubMed ID: 12051912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.
    Poon GM; Brokx RD; Sung M; Gariépy J
    J Mol Biol; 2007 Jan; 365(4):1217-31. PubMed ID: 17113101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
    Pivonková H; Brázdová M; Kaspárková J; Brabec V; Fojta M
    Biochem Biophys Res Commun; 2006 Jan; 339(2):477-84. PubMed ID: 16300733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of a consensus binding site for p53.
    el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
    Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-linked dimerization in the iron-dependent regulator from Mycobacterium tuberculosis.
    Semavina M; Beckett D; Logan TM
    Biochemistry; 2006 Oct; 45(41):12480-90. PubMed ID: 17029403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
    Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
    J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PAb240+ conformation of wild type p53 binds DNA.
    McLure KG; Lee PW
    Oncogene; 1996 Sep; 13(6):1297-303. PubMed ID: 8808704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
    Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments.
    Palecek E; Brázdová M; Cernocká H; Vlk D; Brázda V; Vojtesek B
    Oncogene; 1999 Jun; 18(24):3617-25. PubMed ID: 10380883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain structure and subunit interactions in the type I DNA methyltransferase M.EcoR124I.
    Smith MA; Read CM; Kneale GG
    J Mol Biol; 2001 Nov; 314(1):41-50. PubMed ID: 11724530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of p53 quaternary structure in relation to sequence-specific DNA binding.
    Hainaut P; Hall A; Milner J
    Oncogene; 1994 Jan; 9(1):299-303. PubMed ID: 8302593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding and 3'-5' exonuclease activity in the murine alternatively-spliced p53 protein.
    Shakked Z; Yavnilovitch M; Kalb Gilboa AJ; Kessler N; Wolkowicz R; Rotter V; Haran TE
    Oncogene; 2002 Aug; 21(33):5117-26. PubMed ID: 12140762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.